Ambrx Biopharma (NASDAQ: AMAM)
Ambrx Biopharma Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Ambrx Biopharma Company Info
Ambrx Biopharma Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA.
News & Analysis
Featured Article
Why Shares of Ambrx Biopharma Soared This Week
A big buy by an asset manager spurred interest in the biotech stock.
Jim Halley | Sep 21, 2023
Featured Article
Why Shares of Ambrx Biopharma Jumped This Week
The company reported data on its clinical programs at two conferences this week.
Jim Halley | May 18, 2023
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.